BNIP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.033580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.502310E-02
Normal-vs-Stage2
1.264210E-01
Normal-vs-Stage3
1.045240E-01
Normal-vs-Stage4
1.241400E-01
Stage1-vs-Stage2
1.816050E-01
Stage1-vs-Stage3
5.698600E-01
Stage1-vs-Stage4
3.502800E-01
Stage2-vs-Stage3
5.160800E-01
Stage2-vs-Stage4
6.966200E-01
Stage3-vs-Stage4
7.971200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.012050E-01
Normal-vs-AfricanAmerican
8.843800E-02
Normal-vs-Asian
1.740630E-01
Caucasian-vs-AfricanAmerican
8.417800E-01
Caucasian-vs-Asian
6.457200E-01
AfricanAmerican-vs-Asian
9.086400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.864300E-02
Normal-vs-Female
1.251840E-01
Male-vs-Female
4.072800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.864200E-01
Normal-vs-Age(41-60Yrs)
1.363380E-01
Normal-vs-Age(61-80Yrs)
8.388300E-02
Normal-vs-Age(81-100Yrs)
3.620200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.112800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.813400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.690800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.144230E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.215400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.039600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.743900E-02
Normal-vs-Daily Drinker
1.015810E-01
Normal-vs-Weekly Drinker
9.052100E-02
Normal-vs-Occasional Drinker
1.990650E-01
Normal-vs-Social Drinker
2.209600E-01
Non Drinker-vs-Daily Drinker
8.193200E-01
Non Drinker-vs-Weekly Drinker
9.477000E-01
Non Drinker-vs-Occasional Drinker
4.997000E-01
Non Drinker-vs-Social Drinker
7.335200E-01
Daily Drinker-vs-Weekly Drinker
9.052000E-01
Daily Drinker-vs-Occasional Drinker
6.902000E-01
Daily Drinker-vs-Social Drinker
8.945200E-01
Weekly Drinker-vs-Occasional Drinker
6.423800E-01
Weekly Drinker-vs-Social Drinker
8.311000E-01
Occasional Drinker-vs-Social Drinker
8.401400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.193800E-01
Normal-vs-Grade 2
8.801900E-02
Normal-vs-Grade 3
8.945900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.064400E-01
Grade 1-vs-Grade 3
5.094100E-02
Grade 1-vs-Grade 4
5.193800E-01
Grade 2-vs-Grade 3
1.256020E-01
Grade 2-vs-Grade 4
8.801900E-02
Grade 3-vs-Grade 4
8.945900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.453600E-02
Normal-vs-NonDiabetic
1.006590E-01
Diabetic-vs-NonDiabetic
8.072400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.422440E-02
Normal-vs-NoPancreatitis
1.076160E-01
Pancreatitis-vs-NoPancreatitis
8.170800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.018240E-01
Normal-vs-N1
1.229580E-01
N0-vs-N1
3.006000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.000360E-01
Normal-vs-TP53-NonMutant
8.821800E-02
TP53-Mutant-vs-TP53-NonMutant
1.225650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
